neobookRx
GuidelinesOther guideline

Sensory Organs

  ATC Code S01LA04 Medicine Ranibizumab Indication Sub-retinal neovascular membranes and non resolving macular odema NEMLC Recommendation Not Approved Bevacizumab to be agent for this indication Review Indicators None Date Ratified 10 December 2015   National Essential Medicines List Committee (NEMLC) Tertiary and Quaternary Level Essential Medicines List November 2023

 ATC Code S01LA04
Medicine Ranibizumab
Indication Sub-retinal neovascular membranes and non resolving macular odema
NEMLC Recommendation Not Approved
Bevacizumab to be agent for this indication
Review Indicators None
Date Ratified 10 December 2015

 


National Essential Medicines List Committee (NEMLC)

Tertiary and Quaternary Level Essential Medicines List

November 2023

Drugs mentioned

NeoHealth® ID 19744 · updated 12/14/2023